Indeed, strategies to upregulate surface ALK using ALK inhibitors in neuroblastoma or to upregulate surface CD72 using SHIP1 inhibitors in B-ALL significantly improves CAR T-mediated killing48,50. This evidence concerns the gene CD72 and acute lymphoblastic leukemia.